KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Accumulated Expenses (2019 - 2025)

Aurinia Pharmaceuticals' Other Accumulated Expenses history spans 6 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 61.99% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, up 61.99%, while the annual FY2025 figure was $2.5 million, 61.99% up from the prior year.
  • Other Accumulated Expenses reached $2.5 million in Q4 2025 per AUPH's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $6.5 million in Q3 2021 to a low of $502000.0 in Q1 2022.
  • Average Other Accumulated Expenses over 5 years is $2.2 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 88.79% in 2022, then skyrocketed 294.22% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $4.4 million in 2021, then crashed by 54.31% to $2.0 million in 2022, then increased by 17.46% to $2.4 million in 2023, then tumbled by 35.89% to $1.5 million in 2024, then surged by 61.99% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Other Accumulated Expenses are $2.5 million (Q4 2025), $2.5 million (Q3 2025), and $2.5 million (Q2 2025).